Aristea Kalikaki - Concepedia

Author

Aristea Kalikaki

University of Crete

Also Known As

A Kalikaki, A. Kalikaki, Aristea Kalikaki

Publications

684

Citations

H-Index

Concepts

All Affiliations

University of Crete University Hospital of Heraklion

About

Aristea Kalikaki is an author at University of Crete specializing in oncology, medicine, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	304
2	Pathology	4	4	304
3	Cancer Genetics	3	3	216
4	Health Sciences	1	1	14
5	Immunology	1	1	14

Aristea Kalikaki

Publications

680

Citations

H-Index

Page 1

	Year	Citations
Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC Aristea Kalikaki, Anastasios Koutsopoulos, Maria Trypaki, British Journal of Cancer	2008	207
DNA Repair Gene Polymorphisms Predict Favorable Clinical Outcome in Advanced Non–Small-Cell Lung Cancer Aristea Kalikaki, Maria Kanaki, Helen Vassalou, Clinical Lung Cancer Genome InstabilityOncologyMedicineGeneticsPathology	2009	149
Impact of KRAS, BRAF, PIK3CA Mutations, PTEN, AREG, EREG Expression and Skin Rash in ≥2nd Line Cetuximab-Based Therapy of Colorectal Cancer Patients Zacharenia Saridaki, Maria Tzardi, Chara Papadaki, PLoS ONE	2011	124
Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status Aristea Kalikaki, Anastasios Koutsopoulos, Dora Hatzidaki, Lung Cancer MedicinePathologyK-ras Mutation StatusFront-line ChemotherapyBronchial Neoplasm	2009	88
Combined analysis of KRAS and PIK3CA mutations, MET and PTEN expression in primary tumors and corresponding metastases in colorectal cancer Alexandra Voutsina, Maria Tzardi, Aristea Kalikaki, Modern Pathology OncologyMedicinePten ExpressionColorectal CancerPathology	2012	53
KRAS Genotypic Changes of Circulating Tumor Cells during Treatment of Patients with Metastatic Colorectal Cancer Aristea Kalikaki, Helen Politaki, John Souglakos, PLoS ONE	2014	45
<i>ERCC1</i>SNPs as Potential Predictive Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy Aristea Kalikaki, Alexandra Voutsina, Anastasios Koutsopoulos, Cancer Investigation Prognostic BiomarkersOncologyPotential Predictive BiomarkersTumor HeterogeneityMedicine	2015	14

Page 1